These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3369235)

  • 1. [Nutritive skin circulation in partial ischemia: effect of various vasoactive substances].
    Barker JH; Menger MD; Sack FU; Messmer K
    Vasa; 1988; 17(1):37-41. PubMed ID: 3369235
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of vasoactive substances in prevention of skin necroses].
    Galla TJ; Sätzler RK; Barker JH; Messmer K
    Handchir Mikrochir Plast Chir; 1992 Mar; 24(2):103-9. PubMed ID: 1582610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Venous obstruction plethysmographic studies on the "borrowing-lending phenomenon" during use of pentoxifyllin and naftidrofuryl].
    Heidrich H; Schartl M
    Verh Dtsch Ges Inn Med; 1978; (84):1403-6. PubMed ID: 741978
    [No Abstract]   [Full Text] [Related]  

  • 4. [Peripheral blood flow velocity in arterial occlusive disease during i.v. long term therapy with vasoactive agents. Plethysmographic comparative study].
    Heidrich H; Witt D; Witt E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1750-2. PubMed ID: 347800
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of sudden deafness--naftidrofuryl (Dusodril) and pentoxifylline (Trental) compared].
    Laskawi R; Schrader B; Schröder M; Poser R; von der Brelie R
    Laryngol Rhinol Otol (Stuttg); 1987 May; 66(5):242-5. PubMed ID: 3302568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Walk training and drug treatment in patients with peripheral arterial occlusive disease stage II. A review.
    Spitzer S; Bach R; Schieffer H
    Int Angiol; 1992; 11(3):204-10. PubMed ID: 1460355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].
    Ranft J; Heidrich H; Lammersen T
    J Mal Vasc; 1987; 12(1):78-81. PubMed ID: 3559415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of buflomedil on microcirculation of the skin in acral gangrene].
    Fagrell B; Hermansson IL
    Fortschr Med; 1985 Jan; 103(1-2):23-7. PubMed ID: 3882535
    [No Abstract]   [Full Text] [Related]  

  • 9. Pentoxifylline for mesenteric ischemia.
    Mavrelis PG; Doumanian H
    Am J Gastroenterol; 1987 Feb; 82(2):175. PubMed ID: 3812425
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.
    Di Salvo MM; Ardita G; Giani L; Mugno F; Stevenazzi F; Mazzone A
    Minerva Cardioangiol; 2006 Jun; 54(3):377-81. PubMed ID: 16733512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rheologic effect of naftidrofuryl and pentoxifylline].
    Radtke H; Kiesewetter H; Roggenkamp HG; Jung F
    Med Welt; 1983 Jul; 34(29-30):833-6. PubMed ID: 6621333
    [No Abstract]   [Full Text] [Related]  

  • 12. tcpO2, arterial blood flow and lactate/pyruvate modifications induced by a single dose of naftidrofuryl IV during stage III lower-limb arteriopathies.
    Pointel JP; Thomas C; Mosnier M; Percebois G; Debry G
    Angiology; 1986 Sep; 37(9):647-53. PubMed ID: 3767072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trial treatment of atherosclerosis--derived ischemia of the lower extremities with dusodril (author's transl)].
    Stadnik J; Cieślik R; Jarochowski M; Macyszyn R
    Przegl Lek; 1977; 34(2):309-11. PubMed ID: 866718
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of safety and efficacy of buflomedil and naftidrofuryl in the treatment of intermittent claudication.
    Rosas G; Cerdeyra C; Lucas MA; Parano JR; Villa JJ
    Angiology; 1981 May; 32(5):291-7. PubMed ID: 7235299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents.
    Apollonio A; Castignani P; Magrini L; Angeletti R
    J Int Med Res; 1989; 17(1):28-35. PubMed ID: 2651175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
    Pohle W; Hirche H; Barmeyer J; Schümichen C; Hoffmann G
    Med Welt; 1979 Feb; 30(7):269-72. PubMed ID: 372733
    [No Abstract]   [Full Text] [Related]  

  • 17. [Trental and Cavinton in the treatment of cochleovestibular disorders].
    Hahn A; Holcát M
    Cesk Otolaryngol; 1984 Jul; 33(4):264-7. PubMed ID: 6333291
    [No Abstract]   [Full Text] [Related]  

  • 18. Pentoxifylline and critical leg ischemia.
    Colgan MP; Moore DJ; Shanik GD
    J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S58-60. PubMed ID: 8699863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy of chronic tissue ischemia with improvement of microcirculation].
    Gerzić Z; Dukić V; Milicević M
    Acta Chir Iugosl; 1978; 25(1):71-86. PubMed ID: 626043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug treatment of claudication: vasodilators, hemorrheologic agents, and antiserotonin drugs.
    Taylor LM; Porter JM
    J Vasc Surg; 1986 Feb; 3(2):374-81. PubMed ID: 2935646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.